Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia

被引:25
作者
Larrue, Clement [1 ,2 ]
Mouche, Sarah [1 ,2 ]
Lin, Shan [3 ,4 ]
Simonetta, Federico [1 ,2 ]
Scheidegger, Nastassja K. [3 ,4 ]
Poulain, Laury [1 ,2 ]
Birsen, Rudy [1 ,2 ]
Sarry, Jean-Emmanuel [5 ]
Stegmaier, Kimberly [3 ,4 ]
Tamburini, Jerome [1 ,2 ]
机构
[1] Univ Geneva, Fac Med, Translat Res Ctr Hemato Oncol, Geneva, Switzerland
[2] Swiss Canc Ctr Leman, Lausanne, Switzerland
[3] Boston Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA
[4] Broad Inst & Harvard, Cambridge, MA USA
[5] Univ Toulouse 3 Paul Sabatier, Canc Res Ctr Toulouse, Equipe Labellisee LIGUE 2018, Inserm UMR1037, F-31037 Toulouse, France
关键词
HEMATOPOIETIC STEM-CELLS; MITOFUSIN; 2; PROLIFERATION; VENETOCLAX; MTORC1; DIFFERENTIATION; AZACITIDINE; INHIBITION; DECITABINE; RESISTANT;
D O I
10.1038/s41375-023-01835-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mitochondrial metabolism recently emerged as a critical dependency in acute myeloid leukemia (AML). The shape of mitochondria is tightly regulated by dynamin GTPase proteins, which drive opposing fusion and fission forces to consistently adapt bioenergetics to the cellular context. Here, we showed that targeting mitochondrial fusion was a new vulnerability of AML cells, when assayed in patient-derived xenograft (PDX) models. Genetic depletion of mitofusin 2 (MFN2) or optic atrophy 1 (OPA1) or pharmacological inhibition of OPA1 (MYLS22) blocked mitochondrial fusion and had significant anti-leukemic activity, while having limited impact on normal hematopoietic cells ex vivo and in vivo. Mechanistically, inhibition of mitochondrial fusion disrupted mitochondrial respiration and reactive oxygen species production, leading to cell cycle arrest at the G(0)/G(1) transition. These results nominate the inhibition of mitochondrial fusion as a promising therapeutic approach for AML.
引用
收藏
页码:765 / 775
页数:11
相关论文
共 53 条
[1]   Mitochondrial Dynamics - Mitochondrial Fission and Fusion in Human Diseases [J].
Archer, Stephen L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (23) :2236-2251
[2]   Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia [J].
Aroua, Nesrine ;
Boet, Emeline ;
Ghisi, Margherita ;
Nicolau-Travers, Marie-Laure ;
Saland, Estelle ;
Gwilliam, Ryan ;
de Toni, Fabienne ;
Hosseini, Mohsen ;
Mouchel, Pierre-Luc ;
Farge, Thomas ;
Bosc, Claudie ;
Stuani, Lucille ;
Sabatier, Marie ;
Mazed, Fetta ;
Larrue, Clement ;
Jarrou, Latifa ;
Gandarillas, Sarah ;
Bardotti, Massimiliano ;
Picard, Muriel ;
Syrykh, Charlotte ;
Laurent, Camille ;
Gotanegre, Mathilde ;
Bonnefoy, Nathalie ;
Bellvert, Floriant ;
Portais, Jean-Charles ;
Nicot, Nathalie ;
Azuaje, Francisco ;
Kaoma, Tony ;
Joffre, Carine ;
Tamburini, Jerome ;
Recher, Christian ;
Vergez, Francois ;
Sarry, Jean-Emmanuel .
CANCER DISCOVERY, 2020, 10 (10) :1544-1565
[3]   Rapamycin passes the torch: a new generation of mTOR inhibitors [J].
Benjamin, Don ;
Colombi, Marco ;
Moroni, Christoph ;
Hall, Michael N. .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (11) :868-880
[4]   Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia [J].
Bosc, Claudie ;
Saland, Estelle ;
Bousard, Aurelie ;
Gadaud, Noemie ;
Sabatier, Marie ;
Cognet, Guillaume ;
Farge, Thomas ;
Boet, Emeline ;
Gotanegre, Mathilde ;
Aroua, Nesrine ;
Mouchel, Pierre-Luc ;
Polley, Nathaniel ;
Larrue, Clement ;
Kaphan, Eleonore ;
Picard, Muriel ;
Sahal, Ambrine ;
Jarrou, Latifa ;
Tosolini, Marie ;
Rambow, Florian ;
Cabon, Florence ;
Nicot, Nathalie ;
Poillet-Perez, Laura ;
Wang, Yujue ;
Su, Xiaoyang ;
Fovez, Quentin ;
Kluza, Jerome ;
Arguello, Rafael Jose ;
Mazzotti, Celine ;
Avet-Loiseau, Herve ;
Vergez, Francois ;
Tamburini, Jerome ;
Fournie, Jean-Jacques ;
Tiong, Ing S. ;
Wei, Andrew H. ;
Kaoma, Tony ;
Marine, Jean-Christophe ;
Recher, Christian ;
Stuani, Lucille ;
Joffre, Carine ;
Sarry, Jean-Emmanuel .
NATURE CANCER, 2021, 2 (11) :1204-+
[5]   Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites [J].
Bosc, Claudie ;
Broin, Nicolas ;
Fanjul, Marjorie ;
Saland, Estelle ;
Farge, Thomas ;
Courdy, Charly ;
Batut, Aurelie ;
Masoud, Rawand ;
Larrue, Clement ;
Skuli, Sarah ;
Espagnolle, Nicolas ;
Pages, Jean-Christophe ;
Carrier, Alice ;
Bost, Frederic ;
Bertrand-Michel, Justine ;
Tamburini, Jerome ;
Recher, Christian ;
Bertoli, Sarah ;
Mansat-De Mas, Veronique ;
Manenti, Stephane ;
Sarry, Jean-Emmanuel ;
Joffre, Carine .
NATURE COMMUNICATIONS, 2020, 11 (01)
[6]   Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment [J].
Chen, Xufeng ;
Glytsou, Christina ;
Zhou, Hua ;
Narang, Sonali ;
Reyna, Denis E. ;
Lopez, Andrea ;
Sakellaropoulos, Theodore ;
Gong, Yixiao ;
Kloetgen, Andreas ;
Yap, Yoon Sing ;
Wang, Eric ;
Gavathiotis, Evripidis ;
Tsirigos, Aristotelis ;
Tibes, Raoul ;
Aifantis, Iannis .
CANCER DISCOVERY, 2019, 9 (07) :890-909
[7]   Mitofusin 2 tethers endoplasmic reticulum to mitochondria [J].
de Brito, Olga Martins ;
Scorrano, Luca .
NATURE, 2008, 456 (7222) :605-U47
[8]   RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia [J].
Decroocq, Justine ;
Birsen, Rudy ;
Montersino, Camille ;
Chaskar, Prasad ;
Mano, Jordi ;
Poulain, Laury ;
Friedrich, Chloe ;
Alary, Anne-Sophie ;
Guermouche, Helene ;
Sahal, Ambrine ;
Fouquet, Guillemette ;
Gotanegre, Mathilde ;
Simonetta, Federico ;
Mouche, Sarah ;
Gestraud, Pierre ;
Lescure, Auriane ;
Del Nery, Elaine ;
Bosc, Claudie ;
Grenier, Adrien ;
Mazed, Fetta ;
Mondesir, Johanna ;
Chapuis, Nicolas ;
Ho, Liza ;
Boughalem, Aicha ;
Lelorc'h, Marc ;
Gobeaux, Camille ;
Fontenay, Michaela ;
Recher, Christian ;
Vey, Norbert ;
Guille, Arnaud ;
Birnbaum, Daniel ;
Hermine, Olivier ;
Radford-Weiss, Isabelle ;
Tsantoulis, Petros ;
Collette, Yves ;
Castellano, Remy ;
Sarry, Jean-Emmanuel ;
Pasmant, Eric ;
Bouscary, Didier ;
Kosmider, Olivier ;
Tamburini, Jerome .
LEUKEMIA, 2022, 36 (05) :1237-1252
[9]   Stem cell concepts renew cancer research [J].
Dick, John E. .
BLOOD, 2008, 112 (13) :4793-4807
[10]   Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia [J].
DiNardo, C. D. ;
Jonas, B. A. ;
Pullarkat, V. ;
Thirman, M. J. ;
Garcia, J. S. ;
Wei, A. H. ;
Konopleva, M. ;
Doehner, H. ;
Letai, A. ;
Fenaux, P. ;
Koller, E. ;
Havelange, V. ;
Leber, B. ;
Esteve, J. ;
Wang, J. ;
Pejsa, V. ;
Hajek, R. ;
Porkka, K. ;
Illes, A. ;
Lavie, D. ;
Lemoli, R. M. ;
Yamamoto, K. ;
Yoon, S. -S. ;
Jang, J. -H. ;
Yeh, S. -P. ;
Turgut, M. ;
Hong, W. -J. ;
Zhou, Y. ;
Potluri, J. ;
Pratz, K. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) :617-629